Short Interest in Ascentage Pharma Group International (OTCMKTS:ASPHF) Expands By 12.1%

Ascentage Pharma Group International (OTCMKTS:ASPHF) was the recipient of a large growth in short interest during the month of December. As of December 15th, there was short interest totalling 858,900 shares, a growth of 12.1% from the November 30th total of 766,100 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is presently ? days.

Ascentage Pharma Group International Stock Performance

ASPHF stock opened at $6.45 on Monday. Ascentage Pharma Group International has a 52 week low of $6.45 and a 52 week high of $6.45. The company has a fifty day simple moving average of $6.45 and a two-hundred day simple moving average of $4.04.

Ascentage Pharma Group International Company Profile

Ascentage Pharma Group International, a clinical-stage biotechnology company, engages in developing therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in the United States and Mainland China. Its primary product HQP1351, a BCR-ABL inhibitor targeting BCR-ABL mutants, including those with the T315I mutation.